• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Gut Microbiota-targeted Interventions for Reducing the Incidence, Duration, and Severity of Respiratory Tract Infections in Healthy Non-elderly Adults.靶向肠道微生物群的干预措施可降低健康非老年成年人呼吸道感染的发生率、持续时间和严重程度。
Mil Med. 2021 Feb 26;186(3-4):e310-e318. doi: 10.1093/milmed/usaa261.
2
Orally Ingested Probiotics, Prebiotics, and Synbiotics as Countermeasures for Respiratory Tract Infections in Nonelderly Adults: A Systematic Review and Meta-Analysis.口服益生菌、益生元和合生剂作为非老年成年人呼吸道感染的对策:系统评价和荟萃分析。
Adv Nutr. 2022 Dec 22;13(6):2277-2295. doi: 10.1093/advances/nmac086.
3
Orally Ingested Probiotic, Prebiotic, and Synbiotic Interventions as Countermeasures for Gastrointestinal Tract Infections in Nonelderly Adults: A Systematic Review and Meta-Analysis.口服益生菌、益生元和合生元干预措施作为非老年成年人胃肠道感染的对策:系统评价和荟萃分析。
Adv Nutr. 2023 May;14(3):539-554. doi: 10.1016/j.advnut.2023.02.002. Epub 2023 Feb 22.
4
Preventing Respiratory Tract Infections by Synbiotic Interventions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.通过共生元干预预防呼吸道感染:随机对照试验的系统评价和荟萃分析。
Adv Nutr. 2020 Jul 1;11(4):979-988. doi: 10.1093/advances/nmaa003.
5
Efficacy and safety of probiotics, prebiotics, and synbiotics for the prevention of colorectal cancer and precancerous lesion in high-risk populations: A systematic review and meta-analysis of randomized controlled trials.益生菌、益生元和合生菌预防高危人群结直肠癌和癌前病变的疗效和安全性:随机对照试验的系统评价和荟萃分析。
J Dig Dis. 2024 Jan;25(1):14-26. doi: 10.1111/1751-2980.13247. Epub 2024 Feb 11.
6
The Effects of Prebiotics, Synbiotics, and Short-Chain Fatty Acids on Respiratory Tract Infections and Immune Function: A Systematic Review and Meta-Analysis.益生菌、合生菌和短链脂肪酸对呼吸道感染和免疫功能的影响:系统评价和荟萃分析。
Adv Nutr. 2022 Feb 1;13(1):167-192. doi: 10.1093/advances/nmab114.
7
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.慢性肾脏病患者的合生菌、益生元和益生菌。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.固体器官移植受者的共生元、益生元和益生菌。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2.
10
Microbiota shaping - the effects of probiotics, prebiotics, and fecal microbiota transplant on cognitive functions: A systematic review.微生物群形成 - 益生菌、益生元和粪便微生物群移植对认知功能的影响:系统评价。
World J Gastroenterol. 2021 Oct 21;27(39):6715-6732. doi: 10.3748/wjg.v27.i39.6715.

引用本文的文献

1
The dynamic linkage between covid-19 and nutrition: a review from a probiotics perspective using machine learning and bibliometric analysis.2019冠状病毒病与营养之间的动态联系:基于机器学习和文献计量分析的益生菌视角综述
Front Nutr. 2025 May 9;12:1575130. doi: 10.3389/fnut.2025.1575130. eCollection 2025.
2
Addressing the dynamic nature of reference data: a new nucleotide database for robust metagenomic classification.应对参考数据的动态特性:一个用于可靠宏基因组分类的新核苷酸数据库。
mSystems. 2025 Apr 22;10(4):e0123924. doi: 10.1128/msystems.01239-24. Epub 2025 Mar 20.
3
Microbiota-targeted interventions and clinical implications for maternal-offspring health: An umbrella review of systematic reviews and meta-analyses of randomised controlled trials.靶向微生物组的干预措施及其对母婴健康的临床意义:系统评价和随机对照试验荟萃分析的伞状评价。
J Glob Health. 2024 Sep 13;14:04177. doi: 10.7189/jogh.14.04177.
4
A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines.从综合角度看肠道微生物群与 COVID-19 疫苗的相互作用。
Gut Microbes. 2023 Jan-Dec;15(1):2233146. doi: 10.1080/19490976.2023.2233146.
5
Potential cellular endocrinology mechanisms underlying the effects of Chinese herbal medicine therapy on asthma.中草药治疗哮喘作用的潜在细胞内分泌学机制。
Front Endocrinol (Lausanne). 2022 Aug 16;13:916328. doi: 10.3389/fendo.2022.916328. eCollection 2022.
6
A randomized trial of probiotic supplementation in nurses to reduce stress and viral illness.益生菌补充剂对护士压力和病毒感染影响的随机试验
Sci Rep. 2022 Aug 30;12(1):14742. doi: 10.1038/s41598-022-19104-9.
7
Orally Ingested Probiotics, Prebiotics, and Synbiotics as Countermeasures for Respiratory Tract Infections in Nonelderly Adults: A Systematic Review and Meta-Analysis.口服益生菌、益生元和合生剂作为非老年成年人呼吸道感染的对策:系统评价和荟萃分析。
Adv Nutr. 2022 Dec 22;13(6):2277-2295. doi: 10.1093/advances/nmac086.
8
Microbiota and the Response to Vaccines Against Respiratory Virus.微生物组与呼吸道病毒疫苗反应
Front Immunol. 2022 May 6;13:889945. doi: 10.3389/fimmu.2022.889945. eCollection 2022.
9
Ingestion, Immunity, and Infection: Nutrition and Viral Respiratory Tract Infections.摄入、免疫与感染:营养与病毒性呼吸道感染。
Front Immunol. 2022 Feb 28;13:841532. doi: 10.3389/fimmu.2022.841532. eCollection 2022.
10
Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review.益生菌、益生元、合生元和后生元作为COVID-19预防和治疗佐剂应用的证据与展望:文献计量分析与系统评价
Trends Food Sci Technol. 2022 Feb;120:174-192. doi: 10.1016/j.tifs.2021.12.033. Epub 2022 Jan 2.

本文引用的文献

1
Evaluation of Probiotics for Warfighter Health and Performance.用于战士健康与表现的益生菌评估。
Front Nutr. 2020 Jun 9;7:70. doi: 10.3389/fnut.2020.00070. eCollection 2020.
2
Using Probiotics to Flatten the Curve of Coronavirus Disease COVID-2019 Pandemic.使用益生菌来平缓2019冠状病毒病疫情曲线。
Front Public Health. 2020 May 8;8:186. doi: 10.3389/fpubh.2020.00186. eCollection 2020.
3
The hallmarks of COVID-19 disease.新型冠状病毒疾病的特征。
PLoS Pathog. 2020 May 22;16(5):e1008536. doi: 10.1371/journal.ppat.1008536. eCollection 2020 May.
4
A Systematic Review and Meta-Analysis: The Effectiveness of Probiotics for Viral Gastroenteritis.系统评价和荟萃分析:益生菌治疗病毒性胃肠炎的疗效。
Curr Pharm Biotechnol. 2020;21(11):1042-1051. doi: 10.2174/1389201021666200416123931.
5
Probiotics for the Prevention of Ventilator-Associated Pneumonia: A Meta-Analysis of Randomized Controlled Trials.益生菌预防呼吸机相关性肺炎的Meta 分析:随机对照试验。
Respir Care. 2020 May;65(5):673-685. doi: 10.4187/respcare.07097. Epub 2020 Mar 3.
6
Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020.2019-20 季节性流感疫苗效力的临时估计-美国,2020 年 2 月。
MMWR Morb Mortal Wkly Rep. 2020 Feb 21;69(7):177-182. doi: 10.15585/mmwr.mm6907a1.
7
Preventing Respiratory Tract Infections by Synbiotic Interventions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.通过共生元干预预防呼吸道感染:随机对照试验的系统评价和荟萃分析。
Adv Nutr. 2020 Jul 1;11(4):979-988. doi: 10.1093/advances/nmaa003.
8
International Society of Sports Nutrition Position Stand: Probiotics.国际运动营养学会立场声明:益生菌。
J Int Soc Sports Nutr. 2019 Dec 21;16(1):62. doi: 10.1186/s12970-019-0329-0.
9
Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season.2018-2019 年美国季节性流感 A(H3N2)病毒抗原漂移与疫苗效力的传播。
J Infect Dis. 2020 Jan 1;221(1):8-15. doi: 10.1093/infdis/jiz543.
10
Probiotics Reduce Health Care Cost and Societal Impact of Flu-Like Respiratory Tract Infections in the USA: An Economic Modeling Study.益生菌降低美国类似流感的呼吸道感染的医疗保健成本和社会影响:一项经济建模研究。
Front Pharmacol. 2019 Aug 28;10:980. doi: 10.3389/fphar.2019.00980. eCollection 2019.

靶向肠道微生物群的干预措施可降低健康非老年成年人呼吸道感染的发生率、持续时间和严重程度。

Gut Microbiota-targeted Interventions for Reducing the Incidence, Duration, and Severity of Respiratory Tract Infections in Healthy Non-elderly Adults.

机构信息

Military Nutrition Division, U.S. Army Research Institute of Environmental Medicine, Natick, MA 01760, USA.

出版信息

Mil Med. 2021 Feb 26;186(3-4):e310-e318. doi: 10.1093/milmed/usaa261.

DOI:10.1093/milmed/usaa261
PMID:33137200
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7665594/
Abstract

INTRODUCTION

Respiratory tract infections (RTI), such as those caused by influenza viruses and, more recently, the severe acute respiratory syndrome coronavirus-2, pose a significant burden to military health care systems and force readiness. The gut microbiota influences immune function, is malleable, and may provide a target for interventions aiming to reduce RTI burden. This narrative review summarizes existing evidence regarding the effectiveness of probiotics, prebiotics, and synbiotics, all of which are gut microbiota-targeted interventions, for reducing the burden of RTI in military-relevant populations (i.e., healthy non-elderly adults).

MATERIALS AND METHODS

A systematic search strategy was used to identify recent meta-analyses and systematic reviews of randomized controlled trials conducted in healthy non-elderly adults which examined effects of probiotics, prebiotics, or synbiotics on the incidence, duration, and/or severity of RTI, or on immune responses to vaccinations against viruses that cause RTI. Relevant randomized controlled clinical trials not included in those reports were also identified.

RESULTS

Meta-analyses and multiple randomized controlled trials have demonstrated that certain probiotic strains may reduce the incidence, duration, and/or severity of RTI and improve immune responses to vaccination against RTI-causing pathogens in various populations including healthy non-elderly adults. Fewer randomized controlled trials have examined the effects of prebiotics or synbiotics on RTI-related outcomes in healthy non-elderly adults. Nevertheless, some studies conducted within that population and other populations have observed that certain prebiotics and synbiotics reduce the incidence, duration, and/or severity of RTI or improve immune responses to vaccinations against RTI-causing viruses. However, across all product classes, not all product formulations have shown benefit, and most have not been tested in multiple randomized controlled trials in military-relevant populations.

CONCLUSION

Dietary supplementation with certain gut microbiota-targeted interventions, and certain probiotics in particular, may provide viable strategies for reducing RTI-related illness in military personnel. Research in military populations is warranted to fully understand the magnitude of any military health and cost benefits, and to establish definitive recommendations for use.

摘要

简介

呼吸道感染(RTI),如流感病毒引起的感染,以及最近的严重急性呼吸综合征冠状病毒 2 型引起的感染,给军队的医疗保健系统和战备能力带来了重大负担。肠道微生物群会影响免疫功能,具有可变性,并且可能成为旨在减轻 RTI 负担的干预措施的目标。本综述总结了现有关于益生菌、益生元和合生元(均为肠道微生物群靶向干预措施)在减少与军事相关人群(即健康非老年人)RTI 负担方面的有效性的证据。

材料和方法

使用系统搜索策略来确定最近的荟萃分析和系统评价,这些分析和评价针对健康非老年人进行了随机对照试验,研究了益生菌、益生元或合生元对 RTI 的发生率、持续时间和/或严重程度,或对针对引起 RTI 的病毒的疫苗接种的免疫反应的影响。还确定了未包含在这些报告中的相关随机对照临床试验。

结果

荟萃分析和多项随机对照试验表明,某些益生菌菌株可能降低 RTI 的发生率、持续时间和/或严重程度,并改善针对 RTI 病原体的疫苗接种的免疫反应,包括健康的非老年人。较少的随机对照试验研究了益生元和合生元对健康非老年人 RTI 相关结局的影响。尽管如此,在该人群和其他人群中进行的一些研究观察到,某些益生元和合生元可降低 RTI 的发生率、持续时间和/或严重程度,或改善针对 RTI 病毒的疫苗接种的免疫反应。然而,在所有产品类别中,并非所有产品配方都显示出益处,并且大多数产品尚未在与军事相关的人群中进行多次随机对照试验测试。

结论

通过饮食补充某些肠道微生物群靶向干预措施,特别是某些益生菌,可能为减少军事人员 RTI 相关疾病提供可行的策略。需要在军事人群中进行研究,以充分了解任何军事健康和成本效益的程度,并为其使用建立明确的建议。